In a new press briefing, leaders in infectious diseases share insights and perspectives on the current #hantavirus outbreak, including transmission, incubation and risk to the public. Watch: https://bit.ly/4da42jN

I'm surprised my dad hasn't crashed out over hantavirus by now

idk what's going on with the Claude system prompt but it keeps telling me my research is merely incremental and not truly novel

Two weeks on ID consults → some highlights: • Staph aureus from the urinary tract (yes, really) • “Explosive pleuritis” (still a great name) • Sinus fungal balls that aren’t so scary • Poor CD4 recovery in HIV • And why strep taxonomy = chaos And an A+ team! @nejm.org voices.nejm.org/doi/full/10....

Weekend on call reunion with @pnussenzweig.bsky.social for the first time since I started fellowship.... "I'm not a nephrologist but I can play one on TV I guess" -Dr. @pnussenzweig.bsky.social. Fair enough

"What's your favourite pathogen" I don't have one my favourite thing is actually source control

Thinking about a career in infectious diseases? Join experienced ID physicians and educators next Wednesday, May 6, at 3pm ET for candid insights on fellowship, career pathways and the realities of a career in ID. Register: bit.ly/4mUEVGo

Meningitis outbreak in Gaza: the role of malnutrition, displacement and attacks on healthcare gh.bmj.com/content/11/4...

A rapid molecular test for gonorrhea and chlamydia compared to Gram stain for symptomatic patients in a specialized STI clinic: a randomized controlled trial journals.lww.com/stdjournal/a...

Just one week until the start of Infectious Diseases in Adults 2026, brought to you by Massachusetts General Hospital and Harvard Medical School Professional, Corporate, and Continuing Education! There is still time to register; visit learn.hms.harvard.edu/id

There's nothing more embarrassing than waiting for your order at Coffee Central in the hospital lobby like no matter where you stand you're in the way

Tfw one of the ID fellows in the year ahead of you brings you a sweet treat in the middle of the day

This is one of the things that scares me most about New England

Box #1 is the BEST. We do everything we can to help people get out of Box #4.

One-month treatment for latent tuberculosis. Why aren't we using it? (Hint: We should.) voices.nejm.org/doi/full/10....

In this @nejm.org Voices post, I take on one of the more annoying and pointless rituals of hospital work -- the annual N95 fit test. As one of the respected infection control specialists told me, it's not their fault. And I totally believe them. #idsky #medsky voices.nejm.org/doi/full/10....

#ICYMI The federal agency gave the nod to Meitheal Pharmaceuticals for its antibiotic, Contepo, an intravenous fosfomycin offering a new mechanism of action and a new option for adults with complicated urinary tract infections, including those caused by resistant Gram-negative pathogens. #IDsky

Jill Blumenthal, MD, MAS, offers some insights on the results from a subset of Gilead’s phase 3 PURPOSE 2 study. #IDsky #Medsky

Today's #MondayBites: Prof. Jen Manne-Goehler on promising therapeutic options for people living with #HIV (PLWHIV) with excessive #visceralfat. Watch the full talk on our accredited e-learning module on Improving Metabolic Health in #PLWHIV! 🔗 amededu.co/3VVqMvH #HIVSky #IDSky #MedSky #hiv247

Shout out to sustainability leaders at Harbor-UCLA Pam Lee, MD and Gary Fong, PharmD with the launching of an Antibiotic Waste Calculator (ecorxchoice.com?page=home) as a innovative solution to support antibiotic stewardship and sustainability! See recent newsletter @sidpharm.bsky.social #IDSky

POV: Rheumatology, ID, and Heme/Onc on their way to investigate your fever of unknown origin (ID is Beyoncé) #IDsky

A question for #IDsky folks: Are you calling it Candida auris or Candidozyma auris? The Europeans appear to be going with the latter.

Walensky: “HHS leadership is inching towards a complete vaccine takedown, incrementally chiseling away at our previously trusted systems, leaving behind a shaky, fragmented vaccine facade that is increasingly obscure and untenable and that has already limited vaccine access”

Recent years have seen a dramatic rise in carbapenem-resistant K. pneumoniae which is now recognized as one of the most formidable MDR pathogens worldwide. 🆕🔥The mechanisms of antibiotic resistance & drug resistance transmission of Klebsiella pneumoniae #idsky www.nature.com/articles/s41...

🆕🔥Streptococcal endocarditis: a meta-analysis of species dependant risk by 🌟s @drtoddlee.bsky.social 🌟Updated figure 🌟Infective endocarditis prevalence of streptococcal species vs. proportion of streptococcal species bacteraemia #idsky #EMIMCC www.sciencedirect.com/science/arti...

We are recruiting an Transplant ID faculty at WashU Medicine Infectious Diseases Division. Come work at one of the largest transplant centers in the country with some of THE BEST ID fellows in the world! facultyopportunities.wustl.edu/Posting/Deta...

#TBSky #IDSky

#IDsky Fascinating study using ivermectin once a month during rainy season in children in Kenya 5-15 yrs of age as a mosquitocidal agent to reduce malaria by 27% Management of malaria will end up being a multi pronged approach. DOI: 10.1056/NEJMdo008089

📃Follow-up of UCSF's DoxyPEP trial published. TL;DR ✅std care STI ↘️when started PEP -of course!🤷‍♂ ✅no difference between arms for doxy R in N. gono 🥳 ✅no change in S. aureus/MRSA carriage😅 ❌doxy R in S. aureus ↗️ in doxy arm 😬 #AMR #AntimicrobialResistance #IDSky www.thelancet.com/journals/lan...

During 2018–2024, the percentage of 𝘕. 𝘨𝘰𝘯𝘰𝘳𝘳𝘩𝘰𝘦𝘢𝘦 isolates carrying 𝘵𝘦𝘵𝘔, which confers tetracycline resistance, increased from less than 10% to more than 30% across the United States. Full study results: nej.md/3GALFIE #MedSky #IDSky

It's mosquito season in the US. With climate change, lack of an effective vaccine, & fed research cuts, there are worries dengue will become endemic to a larger part of N. America. ~3700 cases reported last yr in the contiguous US...All contracted abroad except 105 in CA, FL, or TX. 🛟😷 Medsky idsky

Emergence and Spread of Clostridioides difficile Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care Hospital ⭐️ Editor's Choice #IDSky

I will be recruiting new postdocs with start dates end 2025 - early 2026. If you'd like to work at the Pasteur Institute in the heart of Paris surrounded by amazing scientists, reach out to discuss possible projects on SynBio / Bacterial Immunity!

🆕💫Multicenter matched cohort study Among 8492 patients hospitalized patients with community-acquired pneumonia, azithromycin was associated with a lower mortality and more hospital free days compared to doxycycline in combination with beta-lactams #idsky #EMIMCC academic.oup.com/cid/article-...

Recently, I put out a call for people to share their personal experiences with measles, mumps, rubella, and other vaccine-preventable diseases. I heard from dozens of people who discussed their own illnesses as well as those of friends, siblings, and patients. www.statnews.com/2025/05/10/w...

One of the most challenging encounters in the outpatient practice of infectious diseases, summarized here wonderfully in @cidjournal.bsky.social by Drs. Advani and colleagues. Have already used this algorithm several times! doi.org/10.1093/cid/...

Potent antifungals can trigger inflammation in immunosuppressed patients. Dr. Boulware highlights the need to assess immune status via the Damage-Response Framework to guide safe, effective treatment. 🧬 #IDSky

Dr. Boulware’s Ambition-CM trial shows promise for HIV-related cryptococcal meningitis. But for transplant patients, immune responses to antifungal therapy can be harmful. Personalized treatment is key. ⚠️🧠 #IDSky

A new TB vaccine in clinical trials was fully enrolled months ahead of schedule!🗓️ Early community engagement in TB hotspots made this possible. The global collaboration behind this project may deliver the first TB vaccine in over 100 years!🌎🌍🌏 #TBSky #IDSky www.statnews.com/2025/04/28/m...

How good are we at preventing HIV? The latest episode of Beyond Journal Club, a collaboration between @coreimpodcast.bsky.social and NEJM Group, takes a deep dive into the PURPOSE trials, which look at the use of long-acting lenacapavir as PrEP. 🎧 Listen now: nej.md/4lDlNf2 #MedSky #IDSky

As Antibiotic Resistance Surges, Gepotidacin Found Effective Against Gonorrhea #IDSky #MedSky The pill was effective against strains of gonorrhea bacteria that are resistant to existing antibiotics. www.thelancet.com/journals/lan...

Comprehensive review article on #Malaria in NEJM this month. Gave me lots of joy to see not one but two vaccines now listed as prevention tools for use in endemic regions. A reminder of how much progress has been made thanks to scientific research. #IDSky #MedSKy www.nejm.org/doi/full/10....

In the PURPOSE 2 phase 3 trial, the incidence of HIV infection with twice-yearly lenacapavir was lower than both the background incidence and the incidence with emtricitabine–tenofovir disoproxil fumarate. Full trial results and Research Summary: nej.md/4fFWVzJ #MedSky #IDSky

#IDsky This level of destruction will cause generational damage "The elimination of large swaths of highly trained and dedicated employees at HHS..and other offices responsible for protecting America’s health, is counter to the goal of keeping America healthy." www.idsociety.org/news--public...

A friend drove two hours today for her breast cancer chemotherapy only to learn it was canceled due to NIH cuts. Clinical trial ended midstream. No treatment, no restart, no plan, no information. Her bro-in-law's chemo was also canceled.

Exciting early riotrial.bsky.social‬ results a#CROI202525:i-base.info/htb/50530 Ne#bNABsBs so far successful in keeping viral load undetectable in some participants of#HIVtreatmentnt. Also the first time we’ve seen bNABs cause vaccine-like immune response.#RIOtriala#teropavimaba#zinlirvimabab

Please, please, please join me in contacting your congressional representatives IMMEDIATELY to tell Congress to STAND UP AND ACT. Call tool: act.pih.org/foreign-aid-... Email tool: act.pih.org/foreign-aid-...